CCL5 and gastric cancer: Collectively, these results demonstrate that LCN2 attenuates NF‐κB pathway activation by inhibiting K63‐ and M1‐linked ubiquitination of NEMO in an ANXA1‐dependent manner, thereby downregulating CCL5 expression in GC cells.